|
Volumn 58, Issue 2, 2010, Pages 249-250
|
Can we cure erectile dysfunction?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
PHOSPHODIESTERASE V INHIBITOR;
VASCULOTROPIN;
CLINICAL PROTOCOL;
COMORBIDITY;
CORPUS CAVERNOSUM;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
ENDOCRINE DISEASE;
ERECTILE DYSFUNCTION;
EXTRACORPOREAL LITHOTRIPSY;
GENE THERAPY;
HUMAN;
HYPERPROLACTINEMIA;
HYPOGONADISM;
LIFESTYLE MODIFICATION;
MALE;
MALE SEXUAL DYSFUNCTION;
NEOVASCULARIZATION (PATHOLOGY);
NOTE;
PATIENT SAFETY;
PATIENT SATISFACTION;
PENIS ERECTION;
PENIS PROSTHESIS;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
QUESTIONNAIRE;
SCORING SYSTEM;
SOCIAL ASPECT;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIUM;
|
EID: 77955307892
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1016/j.eururo.2010.04.030 Document Type: Editorial |
Times cited : (9)
|
References (8)
|